Tetra Bio-Pharma (TBPMF) Stock Price, News & Analysis

Company Overview

Tetra Bio-Pharma Inc. is a Canadian specialty pharmaceutical company focused on developing cannabinoid-derived medicines. The company’s research programs are intended to address unmet needs in areas such as pain management, oncology-related symptoms and other serious medical conditions.

Tetra Bio-Pharma has developed a portfolio of investigational products, including REDUVO AdVersa, an oral cannabinoid-based drug candidate being studied for pain, and QIXLEE, a cannabinoid-derived formulation developed for potential use in cancer-related pain. The company has also pursued additional clinical and preclinical programs involving cannabinoid-based therapies.

Founded in Canada, Tetra Bio-Pharma has worked with North American regulators and research partners to advance its drug candidates through clinical development. Its activities have primarily focused on the Canadian and U.S. pharmaceutical markets. Guy Chamberland has served as the company’s chief executive officer and has been associated with its regulatory and product-development efforts.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 185,753 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: OTCMKTS:TBPMF
• CIK: N/A
• Web: www.tetrabiopharma.com
• Phone: (833) 977-7575
• Fax: N/A
• Employees: 33
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A